Ovarian Cancer Symposium 2023

The Ovarian Cancer Symposium aims to provide a platform to bring together leading Australian researchers, clinicians and industry representatives for an open and inclusive discussion on the latest developments and advances in the field of ovarian cancer treatment and research. 

Symposium for: 

• Gynaecological Oncologists

• Medical Oncologists

• Researchers

• Oncologists in training

• Gynaecological Nurse Consultants

Our advisory committee consists of Professor David Bowtell, Professor Anna DeFazio AM, Dr Dale Garsed, Dr Niveditha Rajadevan, Dr. Vanessa Alford (OCA) and Sue Hegarty (OCA). 

International speakers

Dr Denarda Dangaj Laniti (Lausanne, Switzerland)

Group leader, Tumor Microenvironment and Biomarker Discovery Laboratory, Department of Oncology, UNIL CHUV Lausanne Branch of Ludwig Institute for Cancer Research Heterogeneity and Immunobiology of High-Grade Serous Ovarian Cancer

A/Prof Kelly Bolton, MD PhD (Washington, US)

Assistant Professor, Division of Oncology, Washington University Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Guest Speakers

• Prof David Bowtell

• Prof Alison Brand

• Prof Clare Scott

• Dr George Au-Yeung

• Dr Monique Topp

• A/Prof Bo Gao

• Dr Nicola Meagher

• Hayley Russell (OCA)

Panel Members

• Dr Yeh Chen Lee

• Dr Michael Burling

• Dr Michelle Harrison

• A/Prof Lyndal Anderson

• Prof Anna DeFazio AM

This one-day event was funded by AstraZeneca and GSK.